Aeovian Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Aeovian Pharmaceuticals, located in the San Francisco Bay Area, is a biopharmaceutical company focused on finding and bringing to market new treatments for rare and age-related illnesses. The company is working on developing drugs that target specific molecular pathways involved in the onset and advancement of diseases, including oxidative, cellular, and environmental stress. Aeovian Pharmaceuticals was established in 2012.
Aeovian Pharmaceuticals has raised $105M across 2 funding rounds on record, the most recent a Series B of $55.0M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aeovian Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Aeovian Pharmaceuticals Funding Rounds
Aeovian Pharmaceuticals raised $50.0M in an undisclosed round announced in Mar 2024.
1.8 years later, a Series B of $55.0M was announced in Dec 2025.
Aeovian Pharmaceuticals Founders and Leadership Team
Contact details for the Aeovian Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Aeovian Pharmaceuticals Funding Compared to Other Biotechnology Startups
Aeovian Pharmaceuticals' latest round of $55.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aeovian Pharmaceuticals in Biotechnology and San Francisco
Companies Similar to Aeovian Pharmaceuticals
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Aeovian Pharmaceuticals Funding FAQs
What does Aeovian Pharmaceuticals do?
Aeovian Pharmaceuticals, located in the San Francisco Bay Area, is a biopharmaceutical company focused on finding and bringing to market new treatments for rare and age-related illnesses. The company is working on developing drugs that target specific molecular pathways involved in the onset and advancement of diseases, including oxidative, cellular, and environmental stress. Aeovian Pharmaceuticals was established in 2012.
How much funding has Aeovian Pharmaceuticals raised?
Aeovian Pharmaceuticals has raised $105M across 2 rounds on record. The most recent is a Series B of $55.0M announced in Dec 2025.
When did Aeovian Pharmaceuticals last raise funding?
Aeovian Pharmaceuticals' most recent funding round on record is a Series B of $55.0M, announced in Dec 2025.
Who founded Aeovian Pharmaceuticals?
FundedIQ lists Stelios Tzannis (Founder) at Aeovian Pharmaceuticals.
Where is Aeovian Pharmaceuticals headquartered?
Aeovian Pharmaceuticals is based in San Francisco, California, United States.
How many employees does Aeovian Pharmaceuticals have?
Aeovian Pharmaceuticals is in the 1-10 employee band.
How does Aeovian Pharmaceuticals' funding compare to other Biotechnology startups?
Aeovian Pharmaceuticals' latest round of $55.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Aeovian Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aeovian Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.